<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property — Live Feed</title><link>https://www.live-feeds.com/feed/beam-therapeutics-sues-chinese-biotech-vc-backed-startup-alleging-theft-of-intellectual-property</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/beam-therapeutics-sues-chinese-biotech-vc-backed-startup-alleging-theft-of-intellectual-property/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Beam Therapeutics Sues Over Alleged Theft of Base Editing Secrets</title><link>https://www.live-feeds.com/feed/beam-therapeutics-sues-chinese-biotech-vc-backed-startup-alleging-theft-of-intellectual-property</link><guid isPermaLink="false">https://www.live-feeds.com/feed/beam-therapeutics-sues-chinese-biotech-vc-backed-startup-alleging-theft-of-intellectual-property#u94332</guid><pubDate>Fri, 02 Oct 2026 09:20:37 +0000</pubDate><description>Gene-editing company Beam Therapeutics filed a lawsuit against a Chinese biotech and a venture-backed startup, claiming a former scientist stole confidential intellectual property regarding base editing. The Cambridge-based company alleges that the scientist misappropriated trade secrets to help co-found YolTech Therapeutics, which subsequently secured venture capital backing. The legal action also targets Serapha Bio, drawing attention to cross-border intellectual property protection within the biotech industry.Why it mattersThe dispute centers on proprietary base editing methods developed by</description></item>
</channel></rss>